1.Clinical profile and etiology of hypopituitarism at the University of Santo Tomas hospital.
Andag-Silva Aimee A. ; Mercado-Asis Leilani B. ; Elumir-Mamba Lucy Anne S. ; Fonte Jay S.
Philippine Journal of Internal Medicine 2010;48(3):23-27
OBJECTIVE: To establish data determining the etiology of hypopituitarism in the University of Santo Tomas Hospital (USTH) and to describe the clinical and biochemical profile of these patients.
METHODOLOGY: A retrospective descriptive study in a tertiary hospital (USTH) involving patients diagnosed by clinical evaluation and biochemical tests to have hypopituitarism, admitted or seen at the outpatient department from January 2001 to December 2009 and whose charts were available for review. The clinical profile, manifestations and biochemical profile were defined and causes of hypopituitarism identified. Descriptive statistics were applied using percentages and frequency distribution.
RESULTS: In the nine-year period (2001-2009), a total of 191 patients were recorded to have hypopituitarism but only 143 (75%) have adequate data available for review. Sixty one (43%) were males and 82 (51%) were females with mean age was 45±6 years. Hypopituitarism was found to be most prevalent in the fourth to fifth decade of life and clinical manifestations were noted with mean duration of 20±4 months. The most predominant documented pituitary hormone deficiency was gonadotrophic hormone (60%) manifesting prominently as decreased libido (82%). The most common target end organ hormone deficiency was secondary adrenal insufficiency (90%) and most prevalent etiology of hypopituitarism was pituitary tumors (40%). Sheehan's syndrome (8%) and tuberculosis (3%) were also noted as a cause of hypopituitarism.
CONCLUSION: This study shows that the leading clinical manifestation and documented hormone deficiency of hypopituitarism is hypogonadism. Pituitary adenoma is the most common cause of hypopituitarism along with its treatment. Other causes not commonly seen in other countries but proved to be more prevalent here include Sheehan's syndrome and tuberculosis infection.
Human ; Male ; Female ; Middle Aged ; Adult ; Adenoma ; Adrenal Insufficiency ; Hypogonadism ; Hypopituitarism ; Libido ; Outpatients ; Pituitary Hormones ; Pituitary Neoplasms ; Prevalence ; Retrospective Studies ; Tertiary Care Centers ; Tuberculosis
2.Chorea Hyperglycemia Basal Ganglia Syndrome: A case report of a rare diabetes complication
Cristina A. Dorado ; Neshreen J. Kingking ; Remirr Theodore P. Nolasco ; Meliza Dadua-Ecal ; Jay S. Fonte
Philippine Journal of Internal Medicine 2024;62(1):326-330
Introduction:
We present a patient with long-standing uncontrolled type 2 diabetes mellitus (T2 DM) who developed
sudden onset of choreiform movement, which rapidly resolved after insulin therapy and haloperidol.
Case Description:
A 53-year-old Filipino male, with T2DM and hypertension for more than 10 years, presented with sudden
onset of hyperkinetic, involuntary, non-patterned, continuous movements of the left upper and lower extremities.
Investigations revealed severe hyperglycemia without acidemia and ketonuria. Cranial computed tomography scan
showed hyperdensity on the right caudate and lentiform nuclei. On cranial magnetic resonance imaging, there was T1-
weighted hyperintense and T2 - weighted hypointense signal involving the right putamen, globus pallidus and caudate.
Cranial magnetic resonance angiography showed stenosis on the cavernous segment of the right internal carotid artery
(ICA), left ICA and middle cerebral artery (MCA) junction, the A1 segment of the left anterior communicating artery and
proximal P2 segments of the bilateral posterior cerebral arteries. The patient was managed with a basal-bolus insulin
regimen to control the blood glucose and haloperidol to manage the extrapyramidal symptoms. Consequently, there was
complete resolution of the involuntary movements.
Conclusion
This case illustrates the importance of a systematic approach to movement disorders and early recognition of
this rare diabetes complication known as chorea hyperglycemia basal ganglia syndrome or diabetic striatopathy.
Movement Disorders
;
Diabetes Complications
3.Transverse myelitis unmasking multiple sclerosis after mRNA COVID-19 vaccine: A case report.
Javish R. Jadwani ; Eloise D. Guadañ ; a ; Cristina A. Dorado ; Alexander D. Abe ; Jay S. Fonte
Philippine Journal of Internal Medicine 2024;62(3):160-165
INTRODUCTION
Demyelinating central nervous system (CNS) disorders such as transverse myelitis (TM) and multiple sclerosis (MS) have been reported with mRNA Covid-19 vaccine. Some cases were relapses of a pre-existing condition but de novo and initial presentation of MS after BNT162b2 COVID-19 mRNA vaccine has very rarely been documented.
CASE DESCRIPTIONWe report a 72-year-old female, right-handed, Filipina, with a one-month history of bilateral lower extremity weakness which occurred 7 days after she received her first booster dose of BNT162b2 mRNA vaccine. This was later accompanied by fecal and urinary incontinence. On examination, she had motor deficit below L1 myotome manifesting with loss of hip flexion, knee extension, dorsiflexion, and plantar flexion. There was also sensory deficit below T10 level with relative 80% sensation of vibratio, proprioception, light touch and complete loss of pain and temperature sensation. The initial impression was Transverse Myelitis which may be related to a post-vaccination state. Spinal magnetic resonance imaging (MRI) revealed long segment enhancing T2W hyperintense lesion at T2 to T7. Cranial MRI revealed ovoid areas of heterogeneous, predominantly T2/FLAIR hyperintense signals exhibiting restricted diffusion in the periventricular white matter of the fronto-parietal lobes. Cerebrospinal fluid (CSF) analysis was negative for infectious causes such as tuberculosis but with high levels of CSF immunoglobulin G. She was then diagnosed to have Multiple Sclerosis (MS) and was treated with high dose oral prednisone. However, there was no improvement in neurological deficits on follow-up.
CONCLUSIONThis case adds to the reported rare cases of initial presentation of MS occurring after vaccination for COVID-19 and the first reported case in the Philippines. Early recognition and prompt treatment is important to improve outcomes.
Human ; Female ; Aged: 65-79 Yrs Old ; Myelitis, Transverse ; Multiple Sclerosis